Bacterial Conjugation

Educational content, not medical advice. For diagnosis or treatment of any infection, consult a qualified clinician.

The bacterial postal service

Bacteria reproduce by dividing in two, so every offspring is a clone — vertical inheritance, parent to daughter. That alone would make adaptation slow. What lets bacteria evolve at terrifying speed is horizontal gene transfer: the ability to acquire genes from neighbors that are not their parents, sometimes from entirely different species. Conjugation is the most powerful of these mechanisms. It is, in effect, a postal service in which one bacterium copies a useful package of genes — a plasmid — and mails it through a physical tube to a recipient that wasn't even related to it.

The package almost always travels as a plasmid: a small, circular, self-replicating piece of DNA separate from the main chromosome. A bacterium can carry zero, one, or many plasmids, and a single plasmid can carry genes for resistance to several antibiotics at once, for heavy-metal tolerance, for toxins, or for the conjugation machinery itself. Plasmids that can drive their own transfer are called conjugative plasmids; they carry a transfer (tra) region encoding everything needed to build the bridge and pump the DNA.

The molecular machinery

The classic model system is the F (fertility) plasmid of Escherichia coli. A cell carrying F is a donor (F-positive, written F⁺); a cell without it is a recipient (F-negative, F⁻). The transfer happens in a defined sequence:

• Pilus extension and mating-pair formation. The donor assembles a conjugative pilus (the "sex pilus"), a thin protein filament built from pilin subunits. It reaches out, contacts a recipient, and retracts to reel the two cells together into a stable mating pair. The pilus is roughly 8 nm wide and can extend several cell-lengths to find a partner.
• Nicking at the origin of transfer. A donor enzyme called a relaxase recognizes a specific site on the plasmid, the origin of transfer (oriT), and cuts one of the two DNA strands. The relaxase stays covalently bound to the cut 5′ end, forming the relaxosome.
• Unwinding and transfer. The nicked strand is unwound from its partner and threaded — 5′ end first — through a type IV secretion system, an ATP-powered protein channel spanning both cell envelopes. Only a single strand crosses; the donor keeps the other strand as a template.
• Complementary-strand synthesis. Both cells now have one strand and synthesize the missing complement. The result is a complete double-stranded plasmid in each cell. The recipient — formerly F⁻ — has become a donor itself.

A crucial detail explains why conjugation is so contagious: the recipient does not lose anything, and the donor does not lose its plasmid. Conjugation is copy-and-paste, not cut-and-paste. One donor can convert many recipients, each of which then becomes a new donor — an exponential chain reaction limited mainly by cell density and contact opportunity.

Hfr strains and chromosome transfer

Sometimes the F plasmid integrates directly into the bacterial chromosome by recombination. A cell in this state is called an Hfr (high-frequency recombination) strain. When an Hfr donor begins conjugation, the transfer machinery starts at the integrated oriT and tries to drag the entire chromosome through the bridge, beginning with whatever chromosomal genes sit nearest the origin.

In practice the fragile mating bridge almost always snaps before the whole chromosome (about 4.6 million base pairs in E. coli) can pass — full transfer would take roughly 100 minutes. Genes close to the origin are transferred early and often; genes far from it rarely make it across. Researchers exploited this in the famous interrupted-mating experiments of the 1950s: by deliberately shaking mating cells apart at timed intervals and seeing which genes had transferred, they reconstructed the order of genes around the chromosome, with time (in minutes) as the unit of map distance — a foundational result in molecular biology.

Why clinicians care: resistance on wheels

Most clinically dangerous conjugative plasmids belong to families defined by incompatibility (Inc) groups — two plasmids of the same Inc group cannot stably coexist in one cell. Plasmids of groups such as IncF, IncN, and IncX are notorious carriers of resistance genes. These plasmids frequently bundle resistance determinants inside mobile genetic elements — transposons that hop between DNA molecules and integrons that capture gene cassettes — so a single plasmid can confer resistance to beta-lactams, aminoglycosides, fluoroquinolones, and sulfonamides simultaneously.

Several of the most feared resistance traits in modern medicine spread by conjugation:

• Extended-spectrum beta-lactamases (ESBLs) such as CTX-M, which inactivate third-generation cephalosporins, ride IncF-type plasmids through E. coli and Klebsiella populations.
• Carbapenemases — KPC, NDM-1, OXA-48 — destroy our last-line carbapenem antibiotics and are plasmid-borne. NDM-1 emerged and disseminated globally within a few years, largely by conjugative spread.
• The mcr-1 gene, conferring resistance to colistin (a drug of last resort), was identified on a conjugative plasmid in 2015 and spread across continents within months.
• Vancomycin resistance (vanA) in enterococci is carried on conjugative transposons and plasmids, and has transferred in the laboratory and the clinic to Staphylococcus aureus.

The body's own ecosystems supply the venue. The gut microbiome packs trillions of bacteria into close contact, often under antibiotic pressure that kills susceptible cells and clears the field for plasmid-bearing survivors. Biofilms — on catheters, prosthetic joints, heart valves, and mucosal surfaces — concentrate cells in a matrix that dramatically raises conjugation rates. This is why a course of antibiotics can leave a patient colonized with a multidrug-resistant organism, and why resistance plasmids slip from harmless commensal E. coli into pathogens like Klebsiella pneumoniae or Salmonella.

Conjugation vs. the other routes of horizontal gene transfer

Conjugation is one of three mechanisms by which bacteria acquire foreign DNA. The differences matter clinically because they govern what kind of DNA moves, how far, and how fast.

Feature	Conjugation	Transformation	Transduction
Vehicle	Pilus + type IV secretion system (cell-to-cell)	Naked DNA from the environment	Bacteriophage (virus)
Donor cell required?	Yes — living donor in physical contact	No — DNA released by lysed cells	No living donor; a phage carries the DNA
DNA usually moved	Plasmids, conjugative transposons; can move whole chromosome (Hfr)	Short chromosomal or plasmid fragments	Random chromosomal fragment or specific genes
Size of transfer	Large (tens to hundreds of kb)	Small fragments	Limited by phage capsid (~tens of kb)
Cross-species reach	Broad — crosses genus boundaries	Limited; needs DNA homology to integrate	Limited by phage host range
Main role in resistance	Dominant — spreads multidrug cassettes	Minor for resistance; key in naturally competent species	Significant in Staphylococcus and some others

The practical upshot: when an epidemiologist sees a multidrug-resistance trait leaping between bacterial species in a hospital, conjugation is the prime suspect. Transformation and transduction tend to move smaller pieces within narrower host ranges.

Can we stop it?

Because conjugation is so central to resistance, blocking it is an attractive target. Several strategies are under investigation:

• Conjugation inhibitors. Certain unsaturated fatty acid derivatives interfere with the relaxase or the type IV secretion ATPases, slowing plasmid transfer without killing the bacteria.
• Anti-pilus agents. Molecules that bind or destabilize the pilus prevent mating-pair formation in the first place.
• CRISPR-based plasmid curing. Engineered systems can be programmed to recognize and cut resistance plasmids, selectively purging them from a population — including delivery by their own conjugative plasmids that spread the "antidote."
• Stewardship. The simplest lever is reducing antibiotic overuse: without the selective pressure that rewards plasmid-bearing cells, resistant clones don't take over, and many plasmids carry a small fitness cost that causes them to be lost over time.

None of these is yet a routine therapy. For now, conjugation remains an invisible engine inside hospitals and communities, quietly mailing resistance genes from cell to cell faster than we can develop new drugs to counter them. Understanding the mechanism is the first step toward jamming the mailroom.